Zhou, Xixin
Luo, Xiaoqing
Li, Qin
Chen, Guihua
Tong, Jin
Deng, Wang
Funding for this research was provided by:
The Second Affiliated Hospital of Chongqing Medical University,
Article History
Received: 6 December 2022
Accepted: 28 October 2023
First Online: 27 November 2023
Declarations
:
: This study was approved by the Ethics Committee of the Second Affiliated Hospital of Chongqing Medical University (Scientific Ethics Review No. 22, 2022). The revised version of the protocol’s sample size and interventions were examined and approved by the Ethics Committee and the Chinese Clinical Trial Registry. Written informed consent to participate will be obtained from all participants. We provide a sample consent form in Additional file InternalRef removed.
: The anonymised results of the study will be written by a trained investigator and published in peer-reviewed journals. All study patients will provide informed consent for the publication of anonymised patient data and study findings. The authorship will reflect the amount of time spent designing the study, collating the data, analysing the results, and writing the manuscript. We are willing to provide a model consent form upon request.
: All authors declare that they have no competing interests.